Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Prendergast, George
Item TypeName
Concept Immunotherapy
Academic Article Marrying immunotherapy with chemotherapy: why say IDO?
Academic Article Inflammatory Reprogramming with IDO1 Inhibitors: Turning Immunologically Unresponsive 'Cold' Tumors 'Hot'.
Academic Article Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer.
Academic Article Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment.
Academic Article Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation.
Academic Article Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer.
Academic Article Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy.
Academic Article Diet effects on colonic health influence the efficacy of Bin1 mAb immunotherapy for ulcerative colitis.
Academic Article Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma.
Academic Article How Cancers Escape Immune Destruction and Mechanisms of Action for the New Significantly Active Immune Therapies: Helping Nonimmunologists Decipher Recent Advances.
Academic Article Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
Academic Article Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function.
Academic Article Intestinal barrier tightening by a cell-penetrating antibody to Bin1, a candidate target for immunotherapy of ulcerative colitis.
Academic Article Classification of current anticancer immunotherapies.
Academic Article Immune escape as a fundamental trait of cancer: focus on IDO.
Grant IDO2 Targeting in Pancreatic Cancer
Grant IDO2 Targeting for pancreatic cancer treatment
Search Criteria
  • Immunotherapy